

for Neurodegenerative Diseases Caused by Protein Misfolding.
| Headquarter | Cambridge, MA United States of America |
|---|---|
| Website | yumanity.com |
| Founding Date | 2014 |
| Tel | (973) 271-6085 |
| Company Status | Private |
Yumanity Therapeutics competitors include Tizona Therapeutics and Vitrolife. See below how Yumanity Therapeutics compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.

Tony Coles CEO / President
Tony Coles serves as the CEO / President of Yumanity Therapeutics.

Marie Epstein Vice President Finance
Marie Epstein serves as the Vice President Finance of Yumanity Therapeutics.

Ken Rhodes Chief Scientific Officer
Ken Rhodes serves as the Chief Scientific Officer of Yumanity Therapeutics. Ken started at Yumanity Therapeutics in...

Paulash Mohsen Chief Business Officer
Paulash Mohsen serves as the Chief Business Officer of Yumanity Therapeutics.

Robert Scannevin Vice President, Discovery Biology
Robert Scannevin serves as the Vice President, Discovery Biology of Yumanity Therapeutics. Robert currently resides in...

Bertrand Bourdonnec Vice President, Medicinal Chemistry & Program Management
Bertrand Bourdonnec serves as the Vice President, Medicinal Chemistry & Program Management of Yumanity Therapeutics....

Matt Lucas Senior Director Of Chemistry
Matt Lucas serves as the Senior Director Of Chemistry of Yumanity Therapeutics.

No Recent Jobs found for Yumanity Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

Who are Yumanity Therapeutics competitors?
Yumanity Therapeutics main competitors are Tizona Therapeutics, Vitrolife
Who is Yumanity Therapeutics leadership?
Marie Epstein, Ken Rhodes & Paulash Mohsen are part of Yumanity Therapeutics leadership, Tony Coles is the CEO